期刊文献+

HPLC-MS-MS测定人血浆中的托烷司琼 被引量:1

HPLC-MS-MS determination of tropisetron in human plasma
下载PDF
导出
摘要 目的建立HPLC-MS-MS方法测定人血浆中托烷司琼浓度。方法色谱柱为Hypurity C18柱(Thermo Hypersil-Keystone,2.1mm×150mm,5μm);流动相为乙腈-0.1%甲酸水溶液-60:40;流速为0.2mL·min^-1,柱温为40℃,自动进样瓶温10℃。采用电喷雾离子源(ESI)正离子模式,用多反应监测模式(MRM)进行定量分析。用于定量分析的托烷司琼和内标的碎片离子分别为m/z 124和m/z 201。结果托烷司琼(TST)线性范围为0.22-57.25ng·mL^-1,决定系数(相关系数r的平方)为0.998,定量下限为0.22ng·mL^-1,提取回收率〉50%,日内和日间RSD均〈15%。结论此方法简便、高效、快速、和灵敏,可用于托烷司琼药动学及生物等效性研究。 Objective To establish a liquid chromatography - electrospray ionization tandem mass spectrum (HPLC- MSMS) method for the determination of tropisetron in human plasma. Methods Chromatographic column was Hypurity C18 (150 min×2. 1 mm, 5μm) ; the mobile phase was composed of methanol: acetonitrile-0. 1% formic acid= 60 : 40, the flow rate was 0.2 mL · min^-1, and the column temperature was 40 ℃ . Results The ionization was optimized using ESI (+) and enhanced selectivity was achieved using tandem mass spectrometric analysis via MRM functions, 285→124 for tropisetron, and 295→201 for inertal standard. The calibration curve was linear at 0.22-57. 25 ng · mL^-1 (r^2= 0. 998) for tropisetron. The extract recovery was more than 50%0. The RSD of inter-day and intraday was less than 15%. Conclusions The method is simple, rapid, efficient, sensitive and suitable for the determination the content of tropisetron in healthy volunteers. It can be used in the pharmacokinetic and bioequivalent research of tropisetron.
出处 《中南药学》 CAS 2008年第4期423-426,共4页 Central South Pharmacy
关键词 液-质联用 托烷司琼 药物代谢动力学 生物等效性 LC-MS tropisetron pharmacokinetics bioequivalence
  • 相关文献

参考文献6

二级参考文献22

  • 1谭明,吴国平,李雪宁,徐红蓉.国产与进口托烷司琼胶囊的人体生物等效性[J].中国临床药学杂志,2004,13(4):208-211. 被引量:2
  • 2付良青,黄丰,唐欣,钱平利,刘泽源.进口盐酸托烷司琼胶囊在中国人体的药代动力学[J].中国药理学通报,2004,20(9):1067-1069. 被引量:4
  • 3Bruijn KM. Tropisetron: A review of the clinical experience [ J ].Drug, 1992 ;43 ( Suppl. 3 ): S11 - S22.
  • 4Haus U, Varga B, Stratz T, et al. Oral treatment of fibromyalgia with tropisetron given over 28 days: influence on functional and vegetative symptoms, psychometric parameters and pain [ J ]. Scand J Rheumatol,2000;29(Suppl. ) : S55 -S58.
  • 5Fischer V, Baldeck JP, Tse FLS. Phannacokinetics and metabolism of the 5 - hydroxytryptamine antagonist tropisetron after single oral doses in humans[ J ]. Drug Metab Dispos, 1992 ;20:603 - 607.
  • 6De Bruijn KM. Tropisetron. A review of the clinical experience.Drugs,1992,43 (Suppl 3) :11
  • 7Lee CR, Plosker GL, McTavish D. Tropisetron. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential as an antiemetic. Drugs, 1993,46 (5) :925
  • 8Bauer S, Stormer E, Kaiser R,et al. Simultaneous determination of ondansetron and tropisetrn in human plasma using HPLC with UV detection. Biomed. Chromatogr,2002,16 : 187
  • 9Kees F, Father L, Bucher M, et al. Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers. Br J Clin Pharmacol,2001,52:705
  • 10Causon R. Validation of chromatographic methods in biomedical analysis: viewpoint and discussion. J Chromatogr B, 1997,689 : 175

共引文献6

同被引文献11

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部